During the past decade, Krakowskie Centrum Medyczne Sp. z o.o. conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 30 clinical trials were completed, i.e. on average, 81.1% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 19 clinical trials were completed. i.e. 135.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Krakowskie Centrum Medyczne Sp. z o.o." #1 sponsor was "Pfizer" with 20 trials, followed by "Galapagos NV" with 5 trials sponsored, "Shire" with 3 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "Radius Health, Inc." with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Krakowskie Centrum Medyczne Sp. z o.o." #1 collaborator was "Gilead Sciences" with 4 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator, "Shire" with 1 trials as a collaborator and "Teva Pharmaceutical Industries, Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Krakowskie Centrum Medyczne Sp. z o.o." are "Ulcerative Colitis" (7 trials), "Psoriasis" (6 trials), "Atopic Dermatitis" (4 trials), "Dermatitis, Atopic" (4 trials) and "Nonalcoholic Fatty Liver Disease" (4 trials). Many other conditions were trialed in "Krakowskie Centrum Medyczne Sp. z o.o." in a lesser frequency.

Most popular intervention types in "Krakowskie Centrum Medyczne Sp. z o.o." are "Drug" (44 trials), "Other" (7 trials), "Biological" (4 trials), "Combination Product" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (29 trials), "Filgotinib" (6 trials), "PF-04965842 100 mg" (3 trials), "PF-04965842 200 mg" (3 trials) and "Abrocitinib 200 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Krakowskie Centrum Medyczne Sp. z o.o." are 43 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Krakowskie Centrum Medyczne Sp. z o.o.". undefined are not yet recruiting, 5 are recruiting, 9 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 26 completed trials in Krakowskie Centrum Medyczne Sp. z o.o., undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Krakowskie Centrum Medyczne Sp. z o.o., 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".